Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: what progress?

G Gitnick1

  • 1Dept. of Medicine, UCLA School of Medicine 90024.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

New hepatitis C virus (HCV) assays enable identification of infected patients and characterization of illness. Understanding the RNA virus, transmission, and chronic nature of hepatitis C infection has advanced.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alginate microbead release assay of angiogenesis.

Methods in molecular medicine·2011
Same author

Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing.

Artificial organs·2001
Same author

Hepatitis C screening strategies in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients.

American journal of nephrology·2001
Same author

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

Hepatology (Baltimore, Md.)·2001
Same author

Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same journal

Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.

Scandinavian journal of gastroenterology. Supplement·2010
Same journal

Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.

Scandinavian journal of gastroenterology. Supplement·2009
Same journal

Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.

Scandinavian journal of gastroenterology. Supplement·2008
Same journal

Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.

Scandinavian journal of gastroenterology. Supplement·2007
Same journal

Abstracts of the XXXVII Nordic Meeting of Gastroenterology, 3-5 May 2006, Vasteras, Sweden.

Scandinavian journal of gastroenterology. Supplement·2006
Same journal

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·2006
See all related articles

Area of Science:

  • Virology
  • Hepatology
  • Immunology

Background:

  • Hepatitis C is a significant global health concern.
  • The development of serologic assays has been crucial for diagnosis and understanding the disease.
  • Hepatitis C virus (HCV) is an RNA virus with specific physical and genetic characteristics.

Purpose of the Study:

  • To review the advancements in serologic assays for hepatitis C.
  • To discuss the characteristics of the hepatitis C virus and its transmission.
  • To describe the clinical manifestations and chronic nature of hepatitis C infection.

Main Methods:

  • Review of existing literature on hepatitis C serologic assays and virology.
  • Analysis of the performance and limitations of early radioimmunoassay and enzyme-linked immunoassay.

Related Experiment Videos

  • Discussion of viral properties including size, genome, and transmission routes.

    • Main Results:

    • New serologic assays allow for improved identification of hepatitis C infected individuals.
    • Hepatitis C virus is a chloroform-sensitive, lipid-coated RNA virus (30-60 nm).
    • Infection can be transmitted via erythrocytes and plasma; antibody detection has a window period of 2-6 months.

    Conclusions:

    • Serologic assays have significantly improved the diagnosis and characterization of hepatitis C.
    • Confirmation with secondary assays is vital due to potential false positives in blood donors.
    • Hepatitis C infection frequently becomes chronic, leading to various clinical outcomes including carrier states or progressive liver disease.